These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 574066

  • 21. Adverse effects of nifedipine therapy on hypertrophic obstructive cardiomyopathy.
    Fedor JM, Stack RS, Pryor DB, Phillips HR.
    Chest; 1983 Apr; 83(4):704-6. PubMed ID: 6682029
    [Abstract] [Full Text] [Related]

  • 22. [Echocardiographic and hemodynamic studies on the influence of verapamil in hypertrophic obstructive cardiomyopathy (author's transl)].
    Schmid P, Pavek P, Klein W.
    Z Kardiol; 1979 Feb; 68(2):89-92. PubMed ID: 570768
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Use of calcium channel blockers in hypertrophic cardiomyopathy.
    Lorell BH.
    Am J Med; 1985 Feb 22; 78(2B):43-54. PubMed ID: 4038850
    [Abstract] [Full Text] [Related]

  • 25. Does verapamil improve left ventricular relaxation in patients with myocardial hypertrophy?
    Hess OM, Murakami T, Krayenbuehl HP.
    Circulation; 1986 Sep 22; 74(3):530-43. PubMed ID: 2943531
    [Abstract] [Full Text] [Related]

  • 26. Effect of surgical reduction of left ventricular outflow obstruction on hemodynamics, coronary flow, and myocardial metabolism in hypertrophic cardiomyopathy.
    Cannon RO, McIntosh CL, Schenke WH, Maron BJ, Bonow RO, Epstein SE.
    Circulation; 1989 Apr 22; 79(4):766-75. PubMed ID: 2924410
    [Abstract] [Full Text] [Related]

  • 27. Expanding the indications for septal myectomy in patients with hypertrophic cardiomyopathy: results of operation in patients with latent obstruction.
    Schaff HV, Dearani JA, Ommen SR, Sorajja P, Nishimura RA.
    J Thorac Cardiovasc Surg; 2012 Feb 22; 143(2):303-9. PubMed ID: 22154797
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Comparison of Valsalva Maneuver, Amyl Nitrite, and Exercise Echocardiography to Demonstrate Latent Left Ventricular Outflow Obstruction in Hypertrophic Cardiomyopathy.
    Ayoub C, Geske JB, Larsen CM, Scott CG, Klarich KW, Pellikka PA.
    Am J Cardiol; 2017 Dec 15; 120(12):2265-2271. PubMed ID: 29054275
    [Abstract] [Full Text] [Related]

  • 30. [Hypertrophic obstructive cardiomyopathy: spontaneous course in comparison to long-term therapy with propranolol and verapamil].
    Haberer T, Hess OM, Jenni R, Krayenbühl HP.
    Z Kardiol; 1983 Sep 15; 72(9):487-93. PubMed ID: 6415946
    [Abstract] [Full Text] [Related]

  • 31. Acute dose-response effects of intravenous disopyramide in hypertrophic obstructive cardiomyopathy.
    Kimball BP, Bui S, Wigle ED.
    Am Heart J; 1993 Jun 15; 125(6):1691-7. PubMed ID: 8498312
    [Abstract] [Full Text] [Related]

  • 32. Treatment of hypertrophic cardiomyopathy: relation to pathological mechanisms.
    Kaltenbach M, Hopf R.
    J Mol Cell Cardiol; 1985 Jul 15; 17 Suppl 2():59-68. PubMed ID: 4040978
    [Abstract] [Full Text] [Related]

  • 33. Effects of intravenous verapamil on hemodynamics in patients with heart disease.
    Singh BN, Roche AH.
    Am Heart J; 1977 Nov 15; 94(5):593-9. PubMed ID: 333889
    [Abstract] [Full Text] [Related]

  • 34. [Comparative study of the effects of verapamil and propranolol therapy in 16 cases of obstructive hypertrophic myocardiopathy].
    Cosnay P, Fauchier JP, Lang M, Casset D, Raynaud P, Lavigne G, Itti R.
    Arch Mal Coeur Vaiss; 1987 Mar 15; 80(3):346-55. PubMed ID: 3113357
    [Abstract] [Full Text] [Related]

  • 35. Acute intravenous versus chronic oral drug effects of verapamil on left ventricular diastolic function in patients with hypertrophic cardiomyopathy.
    Posma JL, Blanksma PK, Van der Wall E, Lie KI.
    J Cardiovasc Pharmacol; 1994 Dec 15; 24(6):969-73. PubMed ID: 7898081
    [Abstract] [Full Text] [Related]

  • 36. Usefulness of Doppler echocardiography for determining hemodynamic improvement with intravenous verapamil in hypertrophic cardiomyopathy.
    Cooper M, Shaddy R, Silverman N, Enderlein M.
    Am J Cardiol; 1985 Jul 01; 56(1):201-2. PubMed ID: 4040320
    [No Abstract] [Full Text] [Related]

  • 37. Standardized Goal-Directed Valsalva Maneuver for Assessment of Inducible Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy.
    Kumar S, Van Ness G, Bender A, Yadava M, Minnier J, Ravi S, McGrath L, Song HK, Heitner SB.
    J Am Soc Echocardiogr; 2018 Jul 01; 31(7):791-798. PubMed ID: 29573929
    [Abstract] [Full Text] [Related]

  • 38. [Unstable stenocardia: hemodynamic effect of the intravenous administration of verapamil].
    Karpov IuA, Gratsianskiĭ NA, Ruda MIa.
    Ter Arkh; 1986 Jul 01; 58(5):81-4. PubMed ID: 3738799
    [No Abstract] [Full Text] [Related]

  • 39. Effect of verapamil on systolic and diastolic coronary blood flow velocity in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy.
    Petkow Dimitrow P, Krzanowski M, Nizankowski R, Szczeklik A, Dubiel JS.
    Heart; 2000 Mar 01; 83(3):262-6. PubMed ID: 10677401
    [Abstract] [Full Text] [Related]

  • 40. Verapamil improves the pacing-induced vasodilatation in symptomatic patients with hypertrophic cardiomyopathy.
    Dimitrow PP, Krzanowski M, Grodecki J, Małecka B, Lelakowski J, Kawecka-Jaszcz K, Szczeklik A, Dubiel JS.
    Int J Cardiol; 2002 Jun 01; 83(3):239-47. PubMed ID: 12036528
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.